In the face of this SARS-CoV-2 pandemic, we are witnessing an increasing number of publications referring to the possible use of existing biomarkers in patients with COVID-19. Applications for biomarkers are wide-ranging and can have a pivotal impact on clinical practice. However, sifting through high volumes of information is time-consuming and no easy task.
In order to simplify this for you, we have selected relevant - and recently published - scientific articles that explore the role of various biomarkers in COVID-19. As the COVID-19 outbreak is recent and not all published articles have been peer-reviewed, we've made sure to indicate which of these references have not benefited from this peer-review.
Here below, we provide you with an overview of key messages with the help of a short summary per biomarker, as well as a summary of each article once you click on the 'Go to Summary' link.
We hope this information is interesting for you, and that in these busy times it can also enable you to support clinicians in their diagnostic and/or prognostic decisions or to improve patient selection for targeted therapies.
As you can imagine, literature is evolving rapidly, and further research will be needed to define the specific role of several biomarkers in COVID-19. In this light, this document is intended as a supporting tool and not as a means of replacing clinical decision-making, which remains the responsibility of the treating physician.